Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Mnuchin Alan G.	2. Issuer Name and Ticker or Trading Symbol Sharecare, Inc. [ SHCR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) C/O FALCON CAPITAL ACQUISITION CORP., 3 COLUMBUS CIRCLE, 24TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 7/1/2021
(Street) NEW YORK, NY 10019 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	7/1/2021		C⁽¹⁾		4643103	A	⁽¹⁾	4643103	I ⁽²⁾	seefootnote ⁽²⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹⁾⁽³⁾	7/1/2021		J ⁽³⁾			1713000	⁽¹⁾	⁽¹⁾	Class A Common Stock	⁽¹⁾⁽³⁾	⁽³⁾	6852000	I ⁽²⁾	seefootnote ⁽²⁾
Class B Common Stock	⁽¹⁾⁽⁴⁾	7/1/2021		D ⁽⁴⁾			1284750	⁽¹⁾	⁽¹⁾	Class A Common Stock	⁽¹⁾⁽⁴⁾	⁽⁴⁾	5567250	I ⁽²⁾	seefootnote ⁽²⁾
Class B Common Stock	⁽¹⁾⁽⁵⁾	7/1/2021		J ⁽⁵⁾			495897	⁽¹⁾	⁽¹⁾	Class A Common Stock	⁽¹⁾⁽⁵⁾	⁽⁵⁾	5071353	I ⁽²⁾	seefootnote ⁽²⁾
Class B Common Stock	⁽¹⁾⁽⁶⁾	7/1/2021		G ⁽⁶⁾			428250	⁽¹⁾	⁽¹⁾	Class A Common Stock	⁽¹⁾⁽⁶⁾	⁽⁶⁾	4643103	I ⁽²⁾	seefootnote ⁽²⁾
Class B Common Stock	⁽¹⁾	7/1/2021		C ⁽¹⁾			4643103	⁽¹⁾	⁽¹⁾	Class A Common Stock	⁽¹⁾	⁽¹⁾	0	I ⁽²⁾	seefootnote ⁽²⁾

Explanation of Responses:
(1)	In connection with the completion of the Issuer's business combination (the "Business Combination") pursuant to the Agreement and Plan of Merger, dated February 12, 2021 (the "Merger Agreement") by and among Falcon Capital Acquisition Corp. ("FCAC"), Sharecare, Inc. ("Legacy Sharecare"), FCAC Merger Sub Inc. ("Merger Sub"), and Colin Daniel solely in his capacity as representative of the stockholders of Legacy Sharecare (the "Representative"), the shares of Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis for no additional consideration. As part of the Business Combination, FCAC changed its name to Sharecare, Inc. (the "Issuer") upon closing of the Business Combination on July 1, 2021 (the "Closing").
(2)	Falcon Equity Investors LLC (the "Sponsor") is the record holder of the securities reported herein. Eagle Falcon JV Co LLC, which is controlled by Mr. Mnuchin, is the managing member of Falcon Equity Investors LLC and has voting and investment discretion with respect to the securities held of record by Falcon Equity Investors LLC. Eagle Falcon JV Co LLC and Mr. Mnuchin each disclaims any beneficial ownership of the securities held by Falcon Equity Investors LLC other than to the extent of any pecuniary interest each may have therein, directly or indirectly.
(3)	Pursuant to the Merger Agreement and that certain Sponsor Agreement, dated February 12, 2021 (the "Sponsor Agreement"), by and among FCAC, Legacy Sharecare and the Sponsor, immediately prior to the effectiveness of the Business Combination, the Sponsor delivered 1,713,000 shares of Class B Common Stock to an escrow agent to be returned to the Sponsor upon the satisfaction of certain conditions or forfeited to the Issuer for cancellation, in accordance with the terms of the Merger Agreement, the Sponsor Agreement and that certain Earnout Escrow Agreement, dated July 1, 2021, by and among the Issuer, the Representative, the Sponsor and Continental Stock Transfer & Trust Company, as escrow agent.
(4)	Pursuant to the Sponsor Agreement, immediately prior to the effectiveness of the Business Combination, the reporting persons automatically surrendered 1,284,750 Class B Common Shares to the Issuer for no consideration.
(5)	Represents certain transactions that were entered into in connection with the Business Combination, immediately prior to the effectiveness of the Business Combination. These were not market transactions and no consideration was received for these transactions.
(6)	Represents a charitable donation that was made in connection with the Business Combination, immediately prior to the effectiveness of the Business Combination. This was not a market transaction and no consideration was received for the gifted shares.

Remarks:
As a result of the Closing, the reporting persons have ceased to beneficially own more than 10% of the outstanding common stock of the Issuer and Falcon Equity Investors LLC and Eagle Falcon JV Co LLC are no longer reporting persons. Mr. Mnuchin remains a director of the Issuer. See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Mnuchin Alan G. C/O FALCON CAPITAL ACQUISITION CORP. 3 COLUMBUS CIRCLE, 24TH FLOOR NEW YORK, NY 10019	X
Falcon Equity Investors LLC 660 MADISON AVENUE 12TH FLOOR NEW YORK, NY 10022		X
Eagle Falcon JV Co LLC 660 MADISON AVENUE 12TH FLOOR NEW YORK, NY 10065		X

Signatures
/s/ Daniel Nussen, Attorney-in-fact for Alan G. Mnuchin		7/6/2021
^**Signature of Reporting Person		Date
/s/ Daniel Nussen, Attorney-in-fact for Falcon Equity Investors LLC		7/6/2021
^**Signature of Reporting Person		Date
/s/ Daniel Nussen, Attorney-in-Fact for Eagle Falcon JV Co LLC		7/6/2021
^**Signature of Reporting Person		Date